GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (NYSE:DGX) » Definitions » Cyclically Adjusted PS Ratio

Quest Diagnostics (Quest Diagnostics) Cyclically Adjusted PS Ratio : 1.79 (As of Apr. 27, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Quest Diagnostics Cyclically Adjusted PS Ratio?

As of today (2024-04-27), Quest Diagnostics's current share price is $134.26. Quest Diagnostics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $74.92. Quest Diagnostics's Cyclically Adjusted PS Ratio for today is 1.79.

The historical rank and industry rank for Quest Diagnostics's Cyclically Adjusted PS Ratio or its related term are showing as below:

DGX' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.26   Med: 1.9   Max: 2.78
Current: 1.81

During the past years, Quest Diagnostics's highest Cyclically Adjusted PS Ratio was 2.78. The lowest was 1.26. And the median was 1.90.

DGX's Cyclically Adjusted PS Ratio is ranked better than
59.26% of 135 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.21 vs DGX: 1.81

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Quest Diagnostics's adjusted revenue per share data for the three months ended in Mar. 2024 was $21.125. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $74.92 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Quest Diagnostics Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Quest Diagnostics's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics Cyclically Adjusted PS Ratio Chart

Quest Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.99 2.11 2.73 2.24 1.85

Quest Diagnostics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.97 1.92 1.64 1.85 1.78

Competitive Comparison of Quest Diagnostics's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Quest Diagnostics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Diagnostics's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Quest Diagnostics's Cyclically Adjusted PS Ratio falls into.



Quest Diagnostics Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Quest Diagnostics's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=134.26/74.92
=1.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Diagnostics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Quest Diagnostics's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=21.125/129.4194*129.4194
=21.125

Current CPI (Mar. 2024) = 129.4194.

Quest Diagnostics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 13.117 100.560 16.881
201409 13.131 100.428 16.922
201412 12.723 99.070 16.621
201503 12.596 99.621 16.364
201506 13.276 100.684 17.065
201509 12.966 100.392 16.715
201512 12.752 99.792 16.538
201603 12.938 100.470 16.666
201606 13.423 101.688 17.084
201609 13.275 101.861 16.867
201612 11.223 101.863 14.259
201703 12.887 102.862 16.214
201706 13.314 103.349 16.673
201709 13.257 104.136 16.476
201712 13.321 104.011 16.575
201803 13.554 105.290 16.660
201806 13.806 106.317 16.806
201809 13.590 106.507 16.514
201812 13.230 105.998 16.153
201903 13.904 107.251 16.778
201906 14.360 108.070 17.197
201909 14.277 108.329 17.057
201912 14.162 108.420 16.905
202003 13.496 108.902 16.039
202006 13.434 108.767 15.985
202009 20.336 109.815 23.966
202012 22.074 109.897 25.995
202103 20.148 111.754 23.333
202106 20.079 114.631 22.669
202109 22.192 115.734 24.816
202112 21.952 117.630 24.152
202203 21.579 121.301 23.023
202206 20.613 125.017 21.339
202209 21.068 125.227 21.773
202212 20.287 125.222 20.967
202303 20.628 127.348 20.964
202306 20.509 128.729 20.619
202309 20.132 129.860 20.064
202312 20.429 129.419 20.429
202403 21.125 129.419 21.125

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Quest Diagnostics  (NYSE:DGX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Quest Diagnostics Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Diagnostics (Quest Diagnostics) Business Description

Traded in Other Exchanges
Address
500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Executives
Luis Diaz director C/O JOUNCE THERAPEUTICS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02138
Michael E Prevoznik officer: Corp VP, Legal & Compliance C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Catherine T. Doherty officer: SVP, Physician Services Bus. C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Timothy M Ring director C/O C.R BARD INC, 730 CENTRAL AVE, MURRAY HILL NJ 07974
Mark E Delaney officer: SVP & Chief Commercial Officer 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS NJ 07094
Mark A Gardner officer: SVP of Molecular Gen & Oncol 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS NJ 07094
Patrick Plewman officer: SVP for Diagnostic Services 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS NJ 07094
Karthik Kuppusamy officer: SVP, Clinical Solutions 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS NJ 07094
Michael J Deppe officer: VP, Corp. Controller & CAO 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS, SECAUCUS NJ 07094
Samer Abdul Samad officer: Executive Vice President & CFO 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Stephen H Rusckowski director, officer: President and CEO C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Tracey Doi director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Gail R Wilensky director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Mark Guinan officer: Senior Vice President & CFO C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Daniel Stanzione director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094

Quest Diagnostics (Quest Diagnostics) Headlines